Morgan Stanley Treace Medical Concepts, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,274,057 shares of TMCI stock, worth $25.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,274,057

Previous 2,831,030 15.65%

Holding current value

$25.6 Million

Previous $18.8 Million 0.87%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $8.45 $2.22 Million - $3.74 Million	443,027 Added 15.65%	3,274,057 $19 Million
Q2 2024 Oct 17, 2024	SELL	$4.17 - $12.62 $1.92 Million - $5.82 Million	-461,038 Reduced 14.0%	2,831,030 $18.8 Million
Q2 2024 Aug 14, 2024	SELL	$4.17 - $12.62 $1.92 Million - $5.82 Million	-461,038 Reduced 14.0%	2,831,030 $18.8 Million
Q1 2024 Oct 17, 2024	BUY	$11.48 - $15.86 $5.29 Million - $7.31 Million	461,038 Added 16.29%	3,292,068 $43 Million
Q1 2024 Aug 16, 2024	BUY	$11.48 - $15.86 $2 Million - $2.76 Million	174,334 Added 5.59%	3,292,068 $43 Million
Q1 2024 May 15, 2024	BUY	$11.48 - $15.86 $2 Million - $2.76 Million	174,334 Added 5.59%	3,292,068 $43 Million
Q4 2023 Aug 16, 2024	BUY	$6.03 - $12.88 $1.73 Million - $3.69 Million	286,704 Added 10.13%	3,117,734 $39.8 Million
Q4 2023 Feb 13, 2024	BUY	$6.03 - $12.88 $17.5 Million - $37.4 Million	2,904,228 Added 1360.26%	3,117,734 $39.8 Million
Q3 2023 Nov 15, 2023	SELL	$12.16 - $24.87 $2.81 Million - $5.75 Million	-231,152 Reduced 51.98%	213,506 $2.8 Million
Q2 2023 Aug 14, 2023	BUY	$23.91 - $27.81 $668,141 - $777,122	27,944 Added 6.71%	444,658 $11.4 Million
Q1 2023 May 15, 2023	BUY	$20.23 - $26.22 $4.72 Million - $6.12 Million	233,531 Added 127.49%	416,714 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$20.54 - $24.67 $1.94 Million - $2.33 Million	94,320 Added 106.14%	183,183 $4.21 Million
Q3 2022 Nov 14, 2022	BUY	$14.71 - $24.18 $731,057 - $1.2 Million	49,698 Added 126.89%	88,863 $1.96 Million
Q2 2022 Oct 27, 2022	BUY	$12.93 - $20.29 $244,092 - $383,034	18,878 Added 93.05%	39,165 $560,000
Q2 2022 Aug 15, 2022	BUY	$12.93 - $20.29 $244,092 - $383,034	18,878 Added 93.05%	39,165 $560,000
Q1 2022 Oct 27, 2022	SELL	$16.73 - $21.58 $315,828 - $407,387	-18,878 Reduced 48.2%	20,287 $384,000
Q1 2022 May 13, 2022	SELL	$16.73 - $21.58 $401,486 - $517,876	-23,998 Reduced 54.19%	20,287 $384,000
Q4 2021 Feb 14, 2022	BUY	$15.48 - $26.52 $629,649 - $1.08 Million	40,675 Added 1126.73%	44,285 $826,000
Q3 2021 Nov 15, 2021	BUY	$24.15 - $30.5 $87,181 - $110,105	3,610 New	3,610 $97,000

Others Institutions Holding TMCI

# of Institutions

138

Shares Held

39.7M

Call Options Held

352K

Put Options Held

269K

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $434M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account